| 5th Jan 2023 7:00 am |
RNS |
Business Update |
| 12th Dec 2022 7:00 am |
RNS |
Two Parsortix posters presented at SABCS |
| 2nd Dec 2022 5:30 pm |
RNS |
Issue of Equity |
| 2nd Nov 2022 7:00 am |
RNS |
Multiple downstream analysis techniques for CTCs |
| 1st Nov 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 1st Nov 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 24th Oct 2022 7:00 am |
RNS |
Parsortix poster presented at ISLB meeting |
| 21st Oct 2022 6:15 pm |
RNS |
Issue of Equity |
| 18th Oct 2022 7:00 am |
RNS |
Streamlining of operations to increase cash runway |
| 17th Oct 2022 2:23 pm |
RNS |
TR-1: Notification of major holdings |
| 12th Oct 2022 7:00 am |
RNS |
First regional distribution agreement |
| 30th Sep 2022 5:30 pm |
RNS |
Issue of Equity |
| 30th Sep 2022 5:30 pm |
RNS |
Holding(s) in Company |
| 29th Sep 2022 7:00 am |
RNS |
Interim Results |
| 29th Sep 2022 7:00 am |
RNS |
Positive headline results from ovarian study |
| 28th Sep 2022 7:00 am |
RNS |
Study using Parsortix in head and neck cancer |
| 13th Sep 2022 7:00 am |
RNS |
New poster presented at ASCP Meeting |
| 12th Sep 2022 7:30 am |
RNS |
Novel assay predicts malignancy in pelvic mass |
| 1st Sep 2022 7:00 am |
RNS |
Notice of Interim Results and Webcast |
| 28th Jul 2022 7:00 am |
RNS |
Novel insight into metastasis in NSCLC patients |
| 20th Jul 2022 2:33 pm |
RNS |
Holding(s) in Company |
| 20th Jul 2022 7:00 am |
RNS |
NEW STUDY OF PARSORTIX SYSTEM IN NSCLC |
| 19th Jul 2022 10:00 am |
RNS |
Director/PDMR Shareholding |
| 15th Jul 2022 7:00 am |
RNS |
Results of Capital Raise |
| 14th Jul 2022 5:24 pm |
RNS |
Retail Offer via PrimaryBid |
| 14th Jul 2022 5:23 pm |
RNS |
Proposed Placing and Retail Offer |
| 8th Jul 2022 5:30 pm |
RNS |
Issue of Equity |
| 29th Jun 2022 4:35 pm |
RNS |
Result of 2022 Annual General Meeting |
| 27th Jun 2022 7:00 am |
RNS |
Spread of breast cancer accelerates during sleep |
| 23rd Jun 2022 6:24 pm |
RNS |
Issue of Equity |
| 22nd Jun 2022 7:00 am |
RNS |
Secured contract from pharma services customer |
| 16th Jun 2022 7:00 am |
RNS |
Predicting immunotherapy response in SCLC |
| 14th Jun 2022 7:00 am |
RNS |
Potential role of invasive cellular protrusions |
| 30th May 2022 7:00 am |
RNS |
Partnership with major United States urology group |
| 27th May 2022 7:00 am |
RNS |
Molecular characterisation of CTCs |
| 25th May 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 25th May 2022 12:30 pm |
RNS |
ANGLE receives FDA clearance for Parsortix |
| 20th May 2022 7:00 am |
RNS |
Prostate Cancer UK funds new study using Parsortix |
| 28th Apr 2022 7:00 am |
RNS |
Preliminary Results |
| 20th Apr 2022 7:00 am |
RNS |
Notice of Preliminary Results and Webcast |
